Literature DB >> 29068676

Cell-Surface Receptor-Ligand Interaction Analysis with Homogeneous Time-Resolved FRET and Metabolic Glycan Engineering: Application to Transmembrane and GPI-Anchored Receptors.

Henning Stockmann1, Viktor Todorovic1, Paul L Richardson1, Violeta Marin1, Victoria Scott1, Clare Gerstein1, Marc Lake1, Leyu Wang1, Ramkrishna Sadhukhan1, Anil Vasudevan1.   

Abstract

Ligand-binding assays are the linchpin of drug discovery and medicinal chemistry. Cell-surface receptors and their ligands have traditionally been characterized by radioligand-binding assays, which have low temporal and spatial resolution and entail safety risks. Here, we report a powerful alternative (GlycoFRET), where terbium-labeled fluorescent reporters are irreversibly attached to receptors by metabolic glycan engineering. For the first time, we show time-resolved fluorescence resonance energy transfer between receptor glycans and fluorescently labeled ligands. We describe GlycoFRET for a GPI-anchored receptor, a G-protein-coupled receptor, and a heterodimeric cytokine receptor in living cells with excellent sensitivity and high signal-to-background ratios. In contrast to previously described methods, GlycoFRET does not require genetic engineering or antibodies to label receptors. Given that all cell-surface receptors are glycosylated, we expect that GlycoFRET can be generalized with applications in chemical biology and biotechnology, such as target engagement, receptor pharmacology, and high-throughput screening.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29068676     DOI: 10.1021/jacs.7b09359

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  6 in total

1.  Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation.

Authors:  Li Zhou; Viktor Todorovic; Steve Kakavas; Bernhard Sielaff; Limary Medina; Leyu Wang; Ramkrishna Sadhukhan; Henning Stockmann; Paul L Richardson; Enrico DiGiammarino; Chaohong Sun; Victoria Scott
Journal:  J Biol Chem       Date:  2017-11-27       Impact factor: 5.157

2.  Controlling cellular distribution of drugs with permeability modifying moieties.

Authors:  Paul L Richardson; Violeta L Marin; Stormy L Koeniger; Aleksandra Baranczak; Julie L Wilsbacher; Peter J Kovar; Patricia E Bacon-Trusk; Min Cheng; Todd A Hopkins; Sandra T Haman; Anil Vasudevan
Journal:  Medchemcomm       Date:  2019-04-18       Impact factor: 3.597

Review 3.  Outstanding questions in developmental ERK signaling.

Authors:  Aleena L Patel; Stanislav Y Shvartsman
Journal:  Development       Date:  2018-07-26       Impact factor: 6.868

4.  Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis.

Authors:  Viktor Todorović; Zhi Su; C Brent Putman; Stevan J Kakavas; Katherine M Salte; Heath A McDonald; Joseph B Wetter; Stephanie E Paulsboe; Qi Sun; Clare E Gerstein; Limary Medina; Bernhard Sielaff; Ramkrishna Sadhukhan; Henning Stockmann; Paul L Richardson; Wei Qiu; Maria A Argiriadi; Rodger F Henry; J Martin Herold; J Brad Shotwell; Steve P McGaraughty; Prisca Honore; Sujatha M Gopalakrishnan; Chaohong C Sun; Victoria E Scott
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

5.  A non-clinical comparative study of IL-23 antibodies in psoriasis.

Authors:  Li Zhou; Yibing Wang; Qi Wan; Fei Wu; Jeffrey Barbon; Robert Dunstan; Stephen Gauld; Mark Konrad; Laura Leys; Richard McCarthy; Marian Namovic; Christine Nelson; Gary Overmeyer; Denise Perron; Zhi Su; Leyu Wang; Susan Westmoreland; Jun Zhang; Rui Zhu; Geertruida Veldman
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

6.  Screening for New Inhibitors of Glycine Transporter 1 and 2 by Means of MS Binding Assays.

Authors:  Thomas M Ackermann; Georg Höfner; Klaus T Wanner
Journal:  ChemMedChem       Date:  2021-07-28       Impact factor: 3.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.